Equities research analysts predict that Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) will post $0.06 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Tabula Rasa HealthCare’s earnings, with the lowest EPS estimate coming in at ($0.02) and the highest estimate coming in at $0.15. Tabula Rasa HealthCare reported earnings of ($0.01) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 700%. The business is scheduled to announce its next quarterly earnings report on Tuesday, November 2nd.
According to Zacks, analysts expect that Tabula Rasa HealthCare will report full-year earnings of $0.11 per share for the current fiscal year, with EPS estimates ranging from ($0.02) to $0.22. For the next financial year, analysts anticipate that the business will post earnings of $0.42 per share, with EPS estimates ranging from ($0.13) to $0.81. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that follow Tabula Rasa HealthCare.
Tabula Rasa HealthCare (NASDAQ:TRHC) last released its earnings results on Thursday, August 5th. The company reported ($0.54) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.35) by ($0.19). Tabula Rasa HealthCare had a negative net margin of 30.27% and a negative return on equity of 34.79%. The company had revenue of $82.31 million during the quarter, compared to the consensus estimate of $81.49 million.
TRHC traded up $0.60 during midday trading on Monday, reaching $29.90. 11,567 shares of the company’s stock were exchanged, compared to its average volume of 314,010. The firm has a market capitalization of $742.81 million, a price-to-earnings ratio of -7.13 and a beta of 0.90. The company has a quick ratio of 1.29, a current ratio of 1.37 and a debt-to-equity ratio of 4.50. Tabula Rasa HealthCare has a one year low of $27.01 and a one year high of $69.31. The business has a 50-day simple moving average of $34.98 and a two-hundred day simple moving average of $41.58.
In related news, President Orsula V. Knowlton sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 14th. The shares were sold at an average price of $46.82, for a total value of $468,200.00. Following the completion of the sale, the president now owns 829,360 shares of the company’s stock, valued at $38,830,635.20. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Michael Greenhalgh sold 2,352 shares of the firm’s stock in a transaction that occurred on Thursday, August 5th. The shares were sold at an average price of $38.08, for a total transaction of $89,564.16. Following the completion of the sale, the chief operating officer now directly owns 166,419 shares of the company’s stock, valued at approximately $6,337,235.52. The disclosure for this sale can be found here. Company insiders own 10.20% of the company’s stock.
Hedge funds have recently made changes to their positions in the business. Eaton Vance Management bought a new position in Tabula Rasa HealthCare in the first quarter valued at approximately $31,000. FORA Capital LLC bought a new position in Tabula Rasa HealthCare in the second quarter valued at approximately $40,000. PNC Financial Services Group Inc. boosted its stake in Tabula Rasa HealthCare by 54.2% in the second quarter. PNC Financial Services Group Inc. now owns 1,315 shares of the company’s stock valued at $66,000 after acquiring an additional 462 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in shares of Tabula Rasa HealthCare during the second quarter worth $85,000. Finally, Alpha Paradigm Partners LLC bought a new position in shares of Tabula Rasa HealthCare during the first quarter worth $134,000. 89.20% of the stock is currently owned by hedge funds and other institutional investors.
Tabula Rasa HealthCare Company Profile
Tabula Rasa Healthcare, Inc is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services.
Featured Story: Stock Symbols, CUSIP and Other Stock Identifiers
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.